|
Post by bradleysbest on Dec 5, 2015 11:29:39 GMT -5
How about SNY just come out & say we are committed to Afrezza & we look forward to some big news / events in 2016! No competitive disadvantage & yet we know that they are working to get things going.
Of course they have to believe in Afrezza.... Am I asking for too much?
|
|
|
Post by mssciguy on Dec 5, 2015 11:52:13 GMT -5
How about SNY just come out & say we are committed to Afrezza & we look forward to some big news / events in 2016! No competitive disadvantage & yet we know that they are working to get things going. Of course they have to believe in Afrezza.... Am I asking for too much? A lot of chatter about Relypsa now , polymer coated oral suspensions, possibly being acquired by SNY finance.yahoo.com/marketpulse/SNYSNY has so much going on now it seems they have lost their focus. Kind of like corporate ADHD. It might be a good idea to look at candid SNY discussion to get some clues? Don't know... but there is the meeting in SD this weekend and some big conferences in Jan -- one on drug delivery, Florida, and a big diabetes conference in the middle east, and possibly more.
|
|
|
Post by avogadro on Dec 5, 2015 13:00:33 GMT -5
How about SNY just come out & say we are committed to Afrezza & we look forward to some big news / events in 2016! No competitive disadvantage & yet we know that they are working to get things going. Of course they have to believe in Afrezza.... Am I asking for too much? You are asking a bunch of haughty, stiff-necked Frenchmen to act like forward-thinking, entrepreneurial Americans. It ain't gonna happen./
|
|
|
Post by mssciguy on Dec 5, 2015 13:06:23 GMT -5
How about SNY just come out & say we are committed to Afrezza & we look forward to some big news / events in 2016! No competitive disadvantage & yet we know that they are working to get things going. Of course they have to believe in Afrezza.... Am I asking for too much? You are asking a bunch of haughty, stiff-necked Frenchmen to act like forward-thinking, entrepreneurial Americans. It ain't gonna happen./ Afrezza is worth much more than a billion dollars... maybe the price was too low.... just take a peek for a reminder of the grueling work that went into this clinicaltrials.gov/ct2/results?term=MannkindHere is a sensible post from ymb.... this makes sense now that we are in Dec 2015 prntscr.com/9ap1b3
|
|
|
Post by cjc04 on Dec 5, 2015 14:28:36 GMT -5
How about SNY just come out & say we are committed to Afrezza & we look forward to some big news / events in 2016! No competitive disadvantage & yet we know that they are working to get things going. Of course they have to believe in Afrezza.... Am I asking for too much? - IF - It has been SNY's intention to keep Afrezza, and their plans for it, a big secret from the world, they have done a great job. So why would they now ruin that effort by making any type of statement just to appease MNKD's shareholders?
|
|
mannitrust
Newbie
One day we will look back and say: what was all that poking about?
Posts: 9
|
Post by mannitrust on Dec 5, 2015 14:35:20 GMT -5
How about SNY just come out & say we are committed to Afrezza & we look forward to some big news / events in 2016! No competitive disadvantage & yet we know that they are working to get things going. Of course they have to believe in Afrezza.... Am I asking for too much? I think SNY lowballed Al and purposely allowing the stock to be pummeled until they can acquire mannkind for pennies on the dollar....horrible bosses 2.
|
|
|
Post by trondisc on Dec 6, 2015 11:44:38 GMT -5
MannKind is worth 5-10 billion as of right now. However Sanofi cannot see that (yet?). Convincing Sanofi that MannKind has something special in their portfolio would require: 1) multiple partnerships beyond Sanofi 2) more time (=money_) I still don't trust Sanofi even though there have been recent "efforts" in the last few months via advertising, improved health insurance coverage, etc. I never check the TV unless hanging out with roomates watching the NFL on *rare* occasion. When I see two Toujeo ad's on *DIFFERENT* NFL games it really p!$$e$ me off. Until further notice, Afrezza continues to be swept under the rug. If only *more* diabetics knew the ultimate alternative this would force the hand of insurance coverage + overseas approval/expansion. Hmmm... -downtrodden long since 3.99 hoping for MannKind's medical field contribution to be significant ;(
|
|
|
Post by slugworth008 on Dec 6, 2015 13:34:22 GMT -5
No it wouldn't be too much to ask. And that IS just one of the maddening aspects of SNY's silence. A simple "We are committed to Afrezza" would suffice. . . but they didn't do that on their CC (crickets/nada) or at their strategic event...3/4 slides. SNY may have corporate ADHD but they are also large enough to multi-task. And the silence hasn't made the PPS golden.
|
|
|
Post by dreamboatcruise on Dec 6, 2015 13:43:41 GMT -5
MannKind is worth 5-10 billion as of right now. However Sanofi cannot see that (yet?). Convincing Sanofi that MannKind has something special in their portfolio would require: 1) multiple partnerships beyond Sanofi 2) more time (=money_) I still don't trust Sanofi even though there have been recent "efforts" in the last few months via advertising, improved health insurance coverage, etc. I never check the TV unless hanging out with roomates watching the NFL on *rare* occasion. When I see two Toujeo ad's on *DIFFERENT* NFL games it really p!$$e$ me off. Until further notice, Afrezza continues to be swept under the rug. If only *more* diabetics knew the ultimate alternative this would force the hand of insurance coverage + overseas approval/expansion. Hmmm... -downtrodden long since 3.99 hoping for MannKind's medical field contribution to be significant ;( We have seen no evidence of improved health insurance coverage. People repeat contrary assertions quite often here, but it is merely repeating someone else's mistake. You don't have any evidence of plans that have improved the coverage, correct?
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Dec 6, 2015 13:48:52 GMT -5
Watch the video of the dedication to Alfred Mann, the Sanofi executive of North American Diabetes had plenty of praise for Al and Afrezza.
|
|
|
Post by stevil on Dec 6, 2015 15:39:08 GMT -5
Watch the video of the dedication to Alfred Mann, the Sanofi executive of North American Diabetes had plenty of praise for Al and Afrezza. How would you feel if I told you I'd give you a million dollars?
|
|
|
Post by mssciguy on Dec 6, 2015 16:44:03 GMT -5
Watch the video of the dedication to Alfred Mann, the Sanofi executive of North American Diabetes had plenty of praise for Al and Afrezza. How would you feel if I told you I'd give you a million dollars? Hey, nice profile pic. Are you in med school or already practicing? Amazing how many doctors follow MNKD. Must be good medicine
|
|
|
Post by stevil on Dec 6, 2015 16:47:26 GMT -5
First year med student. Still a looooooong way to go
|
|
|
Post by mssciguy on Dec 6, 2015 16:50:40 GMT -5
First year med student. Still a looooooong way to go Good for you, just don't take chloral hydrate to get to sleep like Oliver Sacks did while he was in med school (great story-- he got addicted to it and ended up with DTs). Love Oliver Sacks.
|
|
|
Post by rvc on Dec 6, 2015 17:26:34 GMT -5
If it looks like a duck and quacks like a duck, it's a duck. As you correctly point out, SNY has not made one positive statement about Afrezza, not ONE! Certainly both SNY and Mann understand that just one statement that SNY is supportive of Afreza would cause the stock price to explode to the side. But nothing, just the sound of crickets. Many longs are of the opinion(and hope) that SNY is purposely sandbagging Afrezza because of some ulterior motive, like acquiring Afrezza, or maybe even MNKD, on the cheap. Sorry, but I can't by the conspiracy theories. Again, if it looks like a duck and quacks like a duck, it's a duck. Like it or not(I don't because I've lost a lot of money on this stock) it seems clear that the current management team at SNY just isn't into Afrezza, and I expect them to unload it at the earliest opportunity.
|
|